Featured Resources
-
Guidance on Implementability
This document provides guidance on the planning, design and conduct and reporting of clinical trials, so that the results from late-phase clinical trials are optimised for implementability.
-
Consumer Involvement and Engagement Toolkit
The Consumer Involvement and Engagement Toolkit provides practical advice for researchers and research organisations wishing to conduct patient-centred clinical trials.
-
COVID-19
We’ve created this area for COVID-19 information relevant to clinical trials. In line with the national guidance and emphasis on the safety and well-being of patients, research participants and their families, and health care professionals, researchers and other staff involved in patient care and research, ACTA strongly supports the continuation of investigator-led trials, where it is safe to do so, and with due consideration to any protocol amendments appropriate for the current COVID-19 pandemic.
Search Resources
General search and filters
Filter by:
Topics
Type of Resource
Results filtered by:
ACTA Board Charter
ACTA Constitution
Registry Randomised Trial Workshop Biographies
Media Release: Australian Clinical Trials Alliance commends the Health Minister’s vision to expedite clinical trials in Australia
Applying a proportionate approach to consent in comparative effectiveness trials
Registry Randomised Trials Workshop Day 2 Introduction
Registry Randomised Trials Workshop Day 1: Closing Remarks
Consumers in Clinical Trials: Jenny Lam
Consumers in Clinical Trials: Zy Phillips
Consumers in Clinical Trials: Mitch Messer
Registry Randomised Trials Workshop Day 2: Establishing Registries: ANZCA Perioperative Clinical Outcomes Registry
Registry Randomised Trials Workshop Day 2: Closing Remarks